2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidine-3-yl-methyl]-amide | 1422186-62-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidine-3-yl-methyl]-amide
• 英文别名: 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidin-3-yl-methyl]-amide；2-(Tetrahydropyran-4-ylamino)quinazolin-7-carboxylic acid-[(R)-(3-chloro-4-fluorophenyl)-(R)-pyrrolidin-3-ylmethyl]amide；N-[(R)-(3-chloro-4-fluorophenyl)-[(3R)-pyrrolidin-3-yl]methyl]-2-(oxan-4-ylamino)quinazoline-7-carboxamide
• CAS: 1422186-62-6
• 化学式: C₂₅H₂₇ClFN₅O₂
• 分子量: 483.973
• InChiKey: SYKRLDPZXIDMRJ-JPYJTQIMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  88.2
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(S)-pyrrolidin-2-yl-methyl]-amide 、 2-isopropylamino-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidine-3-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(S)-pyrrolidine-3-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-chloro-4-fluoro-phenyl)-(S)-pyrrolidine-3-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidine-3-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide 、 2-((R)-1-cyclopropyl-ethylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-((2R,4S)-4-fluoro-pyrrolidin-2-yl)-methyl]-amide 、 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-((2R,5R)-5-methyl-pyrrolidin-2-yl)-methyl]-amide 、 喹唑啉-2-羧酸 、 生成 2-((S)-2,2,2-trifluoro-1-methyl-ethylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-(S)-pyrrolidin-2-yl-methyl]-amide
  参考文献：
  名称：

  Substituted quinazolines as serine/threonine kinase inhibitors

  摘要：

  化合物的公式为(I)，其中R1、R2、R3和Ar的定义如下，是ERK激酶的抑制剂。还披露了用于治疗过度增殖性疾病的组合物和方法。

  公开号：

  US09187462B2

文献信息

• QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS
  申请人：Blake James F.

  公开号：US20150087664A1

  公开（公告）日：2015-03-26

  Compounds having the formula (I) wherein R 1 , R 2 , R 3 and Ar as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.

  具有公式（I）的化合物，其中R1，R2，R3和Ar如此定义的化合物是ERK激酶的抑制剂。本文还披露了治疗过度增殖性疾病的组合物和方法。
• US9187462B2
  申请人：——

  公开号：US9187462B2

  公开（公告）日：2015-11-17